As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more flexible, data-driven approaches that integrate prior knowledge, reduce sample ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, reflects on the growing role of Bayesian ...

The main focus of this short course will be the Bayesian aspect of it. That means this is a slightly more advanced course requiring some knowledge of basic probability, regression methods, and the R ...

In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.

Cytel Inc., an advanced analytics leader providing quantitative insights to decision-makers in clinical investigation, has announced the launch of East Alloy®. This new platform is a web-native ...

The FDA’s new draft guidance on Bayesian methods in clinical trials has been hailed by some as a breakthrough that could speed drug development. But statisticians and researchers are divided on ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...